Equities

Aimei Health Technology Co Ltd

AFJK:NMQ

Aimei Health Technology Co Ltd

Actions
FinancialsOpen End and Miscellaneous Investment Vehicles
  • Price (USD)10.48
  • Today's Change0.000 / 0.00%
  • Shares traded17.18k
  • 1 Year change--
  • Beta--
Data delayed at least 15 minutes, as of Sep 20 2024 17:58 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in USDIncome statement in USDView more

Income statement information is not available for Aimei Health Technology Co Ltd.
Gross margin--
Net profit margin--
Operating margin--
Return on assets--
Return on equity--
Return on investment--
More ▼

Cash flow in USDView more

Cash flow information is not available for Aimei Health Technology Co Ltd.
Cash flow per share--
Price/Cash flow per share--
Book value per share--
Tangible book value per share--
More ▼

Balance sheet in USDView more

Aimei Health Technology Co Ltd uses little or no debt in its capital structure.
Current ratio1.84
Quick ratio--
Total debt/total equity0.00
Total debt/total capital0.00
More ▼

Growth rates in USD

Growth rate information is not available.
EPS growth(5 years)--
EPS (TTM) vs
TTM 1 year ago
--
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.